<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">Based on available evidence, targeting the cytokine storm should be considered in the current COVID-19 outbreak in patients with severe disease for alleviation patients’ inflammatory status. However, future clinical trials are required to gain more definite conclusion regarding the potential mechanistic connections between blockade of inflammatory cytokines (i.e. IL-6, IL-1 and TNFα) and COVID-19 management in severe patients.</p>
